Altinoz, EyupCetinavci, DilanAbdulkareem Aljumaily, Sara AsaadElbe, HulyaCengil, OsmanBicer, Yasemin2024-09-292024-09-2920241478-64191478-6427https://doi.org/10.1080/14786419.2024.2344180https://hdl.handle.net/20.500.14619/5773Doxorubicin (Dox), an anthracycline antibiotic, is a chemotherapeutic drug for several cancer treatments. However, its clinical usage has been restricted because of severe side effects, including nephrotoxicity. This study aimed to demonstrate the possible nephroprotective effects of crocin (Cr) against Dox-induced oxidative stress, renal inflammation, renal morphology and transforming growth factor-beta (TGF-beta) signalling pathways in Dox-exposed rats. Hence, the rats were injected for 15 d consecutively with saline, six different injections of Dox until the cumulative dose reached 12 mg/kg., daily Cr (40 mg/kg), and Dox + Cr combination. Cr increased the activities of superoxide dismutase (SOD) and catalase (CAT), GSH content and suppressed inflammation and oxidative stress in Dox-exposed rats. Our results were confirmed by immunohistochemical findings that Cr treatment ameliorates the expressions of IL1 beta and TGF-beta in Dox-induced nephrotoxicity. Conclusionally, Cr exhibits adequate nephroprotective effects against Dox-induced nephrotoxicity on rat kidney architecture and tissue function by stabilising cellular redox homeostasis, reducing renal fibrosis and suppressing inflammation. [GRAPHICS] .eninfo:eu-repo/semantics/closedAccessDoxorubicincrocinnephrotoxicityoxidative stressIL1 betaTGF-betaArticle10.1080/14786419.2024.23441802-s2.0-8519123117138662441Q2WOS:001208261200001N/A